Bill Text: IL HB0110 | 2021-2022 | 102nd General Assembly | Engrossed
Bill Title: Amends the Substance Use Disorder Act. Permits the Department of Human Services to approve an entity to operate a safe consumption and overdose prevention services program (program). Requires the Department to establish standards for program approval and training and to adopt any rules that are necessary to license and monitor the program. Sets forth the minimum requirements that an entity must meet to obtain an approval on its application to operate a program. Requires any entity that operates a program to submit a report to the Department that contains specific information, including the number of program participants; the number of hypodermic needles, syringes, and harm reduction supplies distributed for use on-site; and the number of ancillary services provided to family members and the public, including, but not limited to, social service referrals and educational services. Grants immunity from criminal and civil liability to specified persons who participate in or have some involvement with a program approved by the Department. Requires the Department to establish a new intervention license category entitled Harm Reduction Services and to approve or deny an application for a Harm Reduction Services license.
Spectrum: Partisan Bill (Democrat 13-0)
Status: (Introduced - Dead) 2022-03-04 - Rule 19(a) / Re-referred to Rules Committee [HB0110 Detail]
Download: Illinois-2021-HB0110-Engrossed.html
| |||||||
| |||||||
| |||||||
1 | AN ACT concerning health.
| ||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||
3 | represented in the General Assembly:
| ||||||
4 | Section 5. The Substance Use Disorder Act is amended by | ||||||
5 | changing Section 15-10 and by adding Section 5-26 as follows:
| ||||||
6 | (20 ILCS 301/5-26 new) | ||||||
7 | Sec. 5-26. Safe consumption and overdose prevention | ||||||
8 | services. | ||||||
9 | (a) Definitions. As used in this Section: | ||||||
10 | "Department" means the Department of Human Services. | ||||||
11 | "Entity" means any community-based organization that | ||||||
12 | provides educational, health, harm reduction, housing, or | ||||||
13 | social services and any hospital, medical clinic or office, | ||||||
14 | health center, nursing care facility, mental health facility, | ||||||
15 | or other similar entity that provides medical care. | ||||||
16 | "Participant" means an individual who seeks to utilize, | ||||||
17 | utilizes, or has used a program established under this | ||||||
18 | Section. | ||||||
19 | "Program" means a safer consumption and overdose services | ||||||
20 | program established under this Section. | ||||||
21 | (b) Program approval. | ||||||
22 | (1) Notwithstanding the Illinois Controlled Substances | ||||||
23 | Act, the Drug Paraphernalia Control Act, or any other |
| |||||||
| |||||||
1 | provision of law to the contrary, the Department may | ||||||
2 | approve an entity to operate a program in one or more | ||||||
3 | jurisdictions upon satisfaction of the requirements set | ||||||
4 | forth under paragraph (4). The Department shall establish | ||||||
5 | standards for program approval and training and shall | ||||||
6 | adopt any rules that are necessary to license and monitor | ||||||
7 | the program. | ||||||
8 | (2) The Department shall establish a new intervention | ||||||
9 | license category entitled Harm Reduction Services and | ||||||
10 | shall approve or deny an application for a Harm Reduction | ||||||
11 | Services
license in accordance with Section 15-10 of this | ||||||
12 | Act and as established by rule. | ||||||
13 | (3) An entity may make an application for a Harm | ||||||
14 | Reduction Services
license at any time, regardless of | ||||||
15 | previous
applications. | ||||||
16 | (4) The Department may approve a program
under this | ||||||
17 | Section upon submission of an application, on a form | ||||||
18 | prescribed by the Department,
demonstrating that the | ||||||
19 | entity shall, at a minimum: | ||||||
20 | (A) provide a hygienic space where participants | ||||||
21 | may consume their pre-obtained drugs; | ||||||
22 | (B) provide adequate staffing by health care | ||||||
23 | professionals or other trained staff; | ||||||
24 | (C) provide sterile injection supplies, collect | ||||||
25 | used hypodermic needles and syringes, provide secure
| ||||||
26 | hypodermic needle and syringe disposal services, and |
| |||||||
| |||||||
1 | may provide other drug using supplies that reduce | ||||||
2 | harm; | ||||||
3 | (D) provide education on safe consumption | ||||||
4 | practices, proper disposal of hypodermic needles and | ||||||
5 | syringes, and overdose prevention, including written | ||||||
6 | information in, at a minimum, the 4 most commonly | ||||||
7 | spoken languages in the State as determined by the | ||||||
8 | Department; | ||||||
9 | (E) administer first aid, if needed, and monitor | ||||||
10 | participants for potential overdose; | ||||||
11 | (F) provide referrals to substance use disorder | ||||||
12 | treatment, recovery support services, medical,
social | ||||||
13 | determinants of health, and employment and training | ||||||
14 | services; | ||||||
15 | (G) educate participants on the risks of | ||||||
16 | contracting
infectious diseases and provide sexual | ||||||
17 | health
resources and supplies, including, but not | ||||||
18 | limited to, condoms for male and female sex organs; | ||||||
19 | (H) provide participants access to naloxone; | ||||||
20 | (I) provide reasonable and adequate security for | ||||||
21 | the program site and equipment; | ||||||
22 | (J) ensure confidentiality of program participants | ||||||
23 | by using an anonymous unique identifier; | ||||||
24 | (K) train staff members to deliver services | ||||||
25 | offered by the program or attend training provided by | ||||||
26 | the Department, if required; |
| |||||||
| |||||||
1 | (L) establish operating procedures for the program | ||||||
2 | and eligibility criteria for program participants, if | ||||||
3 | not predetermined by the Department; and | ||||||
4 | (M) be designated as or collaborate with an | ||||||
5 | authorized needle and hypodermic syringe access | ||||||
6 | program under the Overdose Prevention and Harm | ||||||
7 | Reduction Act. | ||||||
8 | (c) Reporting. An entity operating a program under this | ||||||
9 | Section shall provide a report to the Department, within the | ||||||
10 | time frame specified by the Department, that shall include: | ||||||
11 | (1) the number of program participants; | ||||||
12 | (2) aggregate information regarding the | ||||||
13 | characteristics of program participants; | ||||||
14 | (3) the number of hypodermic needles, syringes, and | ||||||
15 | harm reduction supplies
distributed for use on-site; | ||||||
16 | (4) the number of overdoses experienced and the number | ||||||
17 | of overdoses reversed on-site; | ||||||
18 | (5) the number of individuals directly and formally | ||||||
19 | referred to other services and the type of service; | ||||||
20 | (6) the number of significant incidents, as defined by | ||||||
21 | the Department, during the specified time frame; and | ||||||
22 | (7) the number of ancillary services provided to | ||||||
23 | family members and the public, including, but not limited | ||||||
24 | to, socials service referrals and educational services. | ||||||
25 | (d) Immunity provided. Notwithstanding the Illinois | ||||||
26 | Controlled Substances Act, the Drug Paraphernalia Control Act, |
| |||||||
| |||||||
1 | or any other provision of law to the contrary, the following | ||||||
2 | persons shall not be arrested, charged, or prosecuted for any | ||||||
3 | criminal offense or be subject to any civil or administrative | ||||||
4 | penalty, including seizure or forfeiture of assets or real | ||||||
5 | property or disciplinary action by a professional licensing | ||||||
6 | board, or be denied any right or privilege, solely for | ||||||
7 | participation or involvement in a program approved by the | ||||||
8 | Department under this Act: | ||||||
9 | (1) a program participant; | ||||||
10 | (2) a staff member or administrator of a program, | ||||||
11 | including a health care professional, manager, employee,
| ||||||
12 | or volunteer; and | ||||||
13 | (3) a property owner who owns real property at which a
| ||||||
14 | program is located and operates.
| ||||||
15 | (20 ILCS 301/15-10)
| ||||||
16 | Sec. 15-10. Licensure categories and services. No person | ||||||
17 | or program may provide the
services or conduct the activities | ||||||
18 | described in this Section without first
obtaining a license | ||||||
19 | therefor from the Department, unless otherwise exempted under | ||||||
20 | this Act. The Department shall, by
rule, provide requirements | ||||||
21 | for each of the following types of licenses and categories of | ||||||
22 | service: | ||||||
23 | (a) Treatment: Categories of service authorized by a | ||||||
24 | treatment license are Early Intervention, Outpatient, | ||||||
25 | Intensive Outpatient/Partial Hospitalization, Subacute |
| |||||||
| |||||||
1 | Residential/Inpatient, and Withdrawal Management. | ||||||
2 | Medication assisted treatment that includes methadone used | ||||||
3 | for an opioid use disorder can be licensed as an adjunct to | ||||||
4 | any of the treatment levels of care specified in this | ||||||
5 | Section. | ||||||
6 | (b) Intervention: Categories of service authorized by | ||||||
7 | an intervention license are DUI Evaluation, DUI Risk | ||||||
8 | Education, Designated Program, Harm Reduction Services, | ||||||
9 | and Recovery Homes for persons in any stage of recovery | ||||||
10 | from a substance use disorder.
| ||||||
11 | The Department may, under procedures established by rule | ||||||
12 | and upon a showing
of good cause for such, exempt off-site | ||||||
13 | services from having to obtain a
separate license for services | ||||||
14 | conducted away from the provider's licensed location.
| ||||||
15 | (Source: P.A. 100-759, eff. 1-1-19 .)
|